PubRank

V del Pozo

Author PubWeight™ 23.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cloning and expression of a major allergen from Cupressus arizonica pollen, Cup a 3, a PR-5 protein expressed under polluted environment. Allergy 2004 1.89
2 Members of the alpha-amylase inhibitors family from wheat endosperm are major allergens associated with baker's asthma. FEBS Lett 1990 1.01
3 Noninvasive methods for assessment of airway inflammation in occupational settings. Allergy 2009 0.99
4 Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol 1998 0.96
5 Recombinant lipid transfer protein Tri a 14: a novel heat and proteolytic resistant tool for the diagnosis of baker's asthma. Clin Exp Allergy 2009 0.91
6 Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis. Allergy 2007 0.89
7 Modulation of the Fc gamma RII and Fc gamma RIII induced by GM-CSF, IFN-gamma and IL-4 on murine eosinophils. Immunology 1994 0.86
8 Aspirin inhibits inducible nitric oxide synthase expression and tumour necrosis factor-alpha release by cultured smooth muscle cells. Eur J Clin Invest 1999 0.86
9 Tropomyosin IgE-positive results are a good predictor of shrimp allergy. Allergy 2011 0.83
10 Molecular cloning and characterization of an IgE-reactive protein from Anisakis simplex: Ani s 1. Mol Biochem Parasitol 2000 0.83
11 Allergy to dermatophagoides in a group of Spanish gypsies: genetic restrictions. Int Arch Allergy Immunol 2001 0.82
12 Release of O2- and LTC4 by murine eosinophils: role of intra- and extracellular calcium. Immunology 1990 0.81
13 Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. J Hepatol 1997 0.81
14 Basophil activation test in a case of systemic hypersensitivity reaction to infliximab with good tolerance to another anti-TNF-alpha agent (adalimumab). J Investig Allergol Clin Immunol 2010 0.80
15 DR7 and DQ2 are positively associated with immunoglobulin-E response to the main antigen of olive pollen (Ole e I) in allergic patients. Hum Immunol 1993 0.80
16 Immunological basis of toxic oil syndrome (TOS). Toxicology 1994 0.79
17 Study of apoptosis in human lymphocytes by toxic substances implicated in toxic oil syndrome. Toxicology 1997 0.78
18 Cutaneous allergy at the supermarket. J Investig Allergol Clin Immunol 2012 0.78
19 Occupational asthma and rhinitis caused by eugenol in a hairdresser. Allergy 2007 0.78
20 Increased body mass index does not lead to a worsening of asthma control in a large adult asthmatic population in Spain. J Investig Allergol Clin Immunol 2010 0.78
21 Genetic restrictions in olive pollen allergy. J Allergy Clin Immunol 2000 0.78
22 Improved method for mRNA extraction from paraffin-embedded tissues. Biotechniques 1995 0.78
23 Update in the understanding of genetic predisposition to olive pollen sensitization. Allergy 2002 0.77
24 Modulation of allergic response by gene-environment interaction: olive pollen allergy. J Investig Allergol Clin Immunol 2007 0.77
25 Ole e I: epitope mapping, cross-reactivity with other Oleaceae pollens and ultrastructural localization. Int Arch Allergy Immunol 1994 0.77
26 Immunological aspects of the toxic oil syndrome. Arch Toxicol Suppl 1997 0.76
27 Nonasthmatic eosinophilic bronchitis in a baker caused by fungal alpha-amylase and wheat flour. J Investig Allergol Clin Immunol 2008 0.76
28 DR2 antigens are associated with severity of disease in toxic oil syndrome (TOS). Tissue Antigens 2000 0.76
29 Allergenicity and cross-reactivity of Senecio pollen: identification of novel allergens using the immunoproteomics approach. Clin Exp Allergy 2008 0.75
30 Erythema multiforme to phenobarbital: involvement of eosinophils and T cells expressing the skin homing receptor. J Allergy Clin Immunol 1997 0.75
31 [New pharmaceutical dosage forms for allergy treatment]. An Sist Sanit Navar 2012 0.75
32 Occupational asthma caused by acrylates in optical laboratory technicians. J Investig Allergol Clin Immunol 2011 0.75
33 Occupational asthma due to western red cedar in a guitar maker. J Investig Allergol Clin Immunol 2012 0.75